Zobrazeno 1 - 10
of 46
pro vyhledávání: '"J P, Feighner"'
Autor:
J. P. Feighner
Publikováno v:
Fortschritte der Neurologie · Psychiatrie. 62:S9-S15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6831c50a5ddfd90c4b4bbb6169ecb4e3
https://doi.org/10.1055/s-2007-1002355
https://doi.org/10.1055/s-2007-1002355
Publikováno v:
The Journal of clinical psychiatry. 62(9)
Background We assessed the tolerability and utility of switching fluoxetine nonresponders to citalopram the day that fluoxetine therapy was stopped. Method Fifty-eight outpatients with DSM-IV major depressive episode and prospectively confirmed nonre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7179c834b0713647c1105204799f61
https://pubmed.ncbi.nlm.nih.gov/11681763
https://pubmed.ncbi.nlm.nih.gov/11681763
Autor:
J P, Feighner
Publikováno v:
The Journal of clinical psychiatry. 60
The syndromes of anxiety and depression may reflect separate disorders with overlapping symptoms. They also may be comorbid or reflect illnesses with similar underlying pathophysiology based upon a spectrum of central nervous system dysfunction. Anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7125604aac13ec1b5ef7b6afd4f10b6e
https://pubmed.ncbi.nlm.nih.gov/10634351
https://pubmed.ncbi.nlm.nih.gov/10634351
Autor:
J P, Feighner
Publikováno v:
The Journal of clinical psychiatry. 60
The psychopharmacology of depression is a field that has evolved rapidly in just under 5 decades. Early antidepressant medications--tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs)--were discovered through astute clinical obs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2cd93af0cfe8e3c7329d3f3141c69d14
https://pubmed.ncbi.nlm.nih.gov/10086478
https://pubmed.ncbi.nlm.nih.gov/10086478
Autor:
J P, Feighner
Publikováno v:
The Journal of clinical psychiatry. 56(12)
Cardiovascular side effects from antidepressant drugs, including clinically significant blood pressure changes, conduction disturbances, and arrhythmias may complicate long-term therapy. Cardiovascular effects are most common with tricyclic antidepre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbfe1753337ea5ddc436ca0c5427fdc0
https://pubmed.ncbi.nlm.nih.gov/8530334
https://pubmed.ncbi.nlm.nih.gov/8530334
Autor:
J A, Ascher, J O, Cole, J N, Colin, J P, Feighner, R M, Ferris, H C, Fibiger, R N, Golden, P, Martin, W Z, Potter, E, Richelson
Publikováno v:
The Journal of clinical psychiatry. 56(9)
The mechanism of action of the novel antidepressant bupropion remains unclear after many years of study. A review of the relevant biochemical, in vivo brain microdialysis, electrophysiologic, behavioral, and clinical data clarifies what is known abou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3610c29d3ffa1586c0733fb4dd8626df
https://pubmed.ncbi.nlm.nih.gov/7665537
https://pubmed.ncbi.nlm.nih.gov/7665537
Publikováno v:
Journal of clinical psychopharmacology. 14(6)
The purpose of this study is to evaluate the novel antidepressant venlafaxine for the management of treatment-resistant unipolar depression. We gave unblinded venlafaxine to 84 consecutive outpatients and inpatients who met DSM-III-R criteria for maj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd8f09ae07930541044874d67b387d17
https://pubmed.ncbi.nlm.nih.gov/7884023
https://pubmed.ncbi.nlm.nih.gov/7884023
Autor:
J P, Feighner
Publikováno v:
The Journal of clinical psychiatry. 55
The antidepressant venlafaxine has a unique chemical structure and neuropharmacologic profile. It significantly inhibits reuptake of both serotonin and norepinephrine and lacks notable muscarinic-cholinergic or alpha-adrenergic effects. Premarketing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f94ba1fd220c4f8ca1f471ee438fb7af
https://pubmed.ncbi.nlm.nih.gov/7961545
https://pubmed.ncbi.nlm.nih.gov/7961545
Autor:
J P, Feighner
Publikováno v:
Fortschritte der Neurologie-Psychiatrie. 62
The SSRIs are a new class of effective antidepressant agents which have proven efficacy in a wide range of psychiatric applications. They are as effective as the tricyclic antidepressants and are better tolerated. The SSRIs are safe in overdose and h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c4e99661302a6e74b52ed628f342644
https://pubmed.ncbi.nlm.nih.gov/7959528
https://pubmed.ncbi.nlm.nih.gov/7959528
Autor:
D L, Dunner, J B, Cohn, T, Walshe, C K, Cohn, J P, Feighner, R R, Fieve, J P, Halikas, J T, Hartford, E D, Hearst, E C, Settle
Publikováno v:
The Journal of clinical psychiatry.
Depressive illness among the elderly is an important public health concern. However, treatment of the elderly may be complicated by age-related changes in physiology, general medical status, and susceptibility to side effects. There is therefore a ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f127d0b5f4cbfcc0f540a5b4656db19b
https://pubmed.ncbi.nlm.nih.gov/1531827
https://pubmed.ncbi.nlm.nih.gov/1531827